Sca-1 expression defines developmental stages of mouse pDCs that show functional heterogeneity in the endosomal but not lysosomal TLR9 response

European Journal of Immunology

Volumn 43, Issue 11, 2013, Pages 2993-3005

  Niederquell, Marina ^a   Kurig, Stefanie ^a   Fischer, Jens A A ^a,b   Tomiuk, Stefan ^a   Swiecki, Melissa ^c   Colonna, Marco ^c   Johnston, Ian C D ^a   Dzionek, Andrzej ^a  

^a MILTENYI BIOTEC GMBH   (Germany)

^b ROCHE INNOVATION CENTER MUNICH   (Germany)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IFN ; Plasmacytoid dendritic cells (pDCs); Sca 1; TLR9

Indexed keywords

ALPHA INTERFERON; OSTEOPONTIN; STEM CELL ANTIGEN 1; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL HETEROGENEITY; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOSOME; FEMALE; GENE EXPRESSION; INTRACELLULAR SIGNALING; LYMPHOID ORGAN; LYSOSOME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; UPREGULATION;

IFN-Α; PLASMACYTOID DENDRITIC CELLS (PDCS); SCA-1; TLR9;

ANIMALS; ANTIGENS, LY; CELL PROLIFERATION; DENDRITIC CELLS; ENDOSOMES; FEMALE; GENE EXPRESSION; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; LYSOSOMES; MEMBRANE PROTEINS; MICE; MICE, INBRED AKR; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; OSTEOPONTIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; UP-REGULATION;

EID: 84888042151     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343498     Document Type: Article

References (54)

1. Medzhitov, R., Recognition of microorganisms and activation of the immune response. Nature 2007. 449: 819-826.
2. Colonna, M., Trinchieri, G. and Liu, Y. J., Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004. 5: 1219-1226.
3. McKenna, K., Beignon, A. S. and Bhardwaj, N., Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 2005. 79: 17-27.
4. Liu, Y. J., IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005. 23: 275-306.
5. Zucchini, N., Bessou, G., Robbins, S. H., Chasson, L., Raper, A., Crocker, P. R. and Dalod, M., Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int. Immunol. 2007. 20: 45-56.
6. Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A. and Colonna, M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999. 5: 919-923.
7. Yoneyama, H., Matsuno, K., Zhang, Y., Nishiwaki, T., Kitabatake, M., Ueha, S., Narumi, S. et al., Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 2004. 16: 915-928.
8. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z. K., Endres, S. et al., Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 2154-2163.
9. Kerkmann, M., Rothenfusser, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., Giese, T. et al., Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 2003. 170: 4465-4474.
10. Jaehn, P. S., Zaenker, K. S., Schmitz, J. and Dzionek, A., Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon. Eur. J. Immunol. 2008. 38: 1822-1832.
11. Björck, P., Leong, H. X. and Engleman, E. G., Plasmacytoid dendritic cell dichotomy: identification of IFN-alpha producing cells as a phenotypically and functionally distinct subset. J. Immunol. 2011. 186: 1477-1485.
12. Schlitzer, A., Loschko, J., Mair, K., Vogelmann, R., Henkel, L., Einwachter, H., Schiemann, M. et al., Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs. Blood 2011. 117: 6562-6570.
13. Schwab, N., Zozulya, A. L., Kieseier, B. C., Toyka, K. V. and Wiendl, H., An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. J. Immunol. 2010. 184: 5368-5374.
14. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. et al., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005. 434: 1035-1040.
15. Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K. et al., Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004. 5: 1061-1068.
16. Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y. et al., Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2004. 101: 15416-15421.
17. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N. et al., IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005. 434: 772-777.
18. Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S. et al., Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005. 434: 243-249.
19. Shinohara, M. L., Lu, L., Bu, J., Werneck, M. B., Kobayashi, K. S., Glimcher, L. H. and Cantor, H., Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 2006. 7: 498-506.
20. Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A. et al., Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001. 2: 1144-1150.
21. Blasius, A. L., Cella, M., Maldonado, J., Takai, T. and Colonna, M., Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 2006. 107: 2474-2476.
22. Blasius, A. L., Giurisato, E., Cella, M., Schreiber, R. D., Shaw, A. S. and Colonna, M., Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 2006. 177: 3260-3265.
23. Codias, E. K., Cray, C., Baler, R. D., Levy, R. B. and Malek, T. R., Expression of Ly-6A/E alloantigens in thymocyte and T-lymphocyte subsets: variability related to the Ly-6a and Ly-6b haplotypes. Immunogenetics 1989. 29: 98-107.
24. Yang, L., Kobie, J. J. and Mosmann, T. R., CD73 and Ly-6A/E distinguish in vivo primed but uncommitted mouse CD4 T cells from type 1 or type 2 effector cells. J. Immunol. 2005. 175: 6458-6464.
25. Spangrude, G. J. and Brooks, D. M., Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells. Blood 1993. 82: 3327-3332.
26. Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y. and Colonna, M., Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 2010. 33: 955-966.
27. Gerdes, J., Schwab, U., Lemke, H. and Stein, H., Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983. 31: 13-20.
28. Dumont, F. J. and Coker, L. Z., Interferon-alpha/beta enhances the expression of Ly-6 antigens on T cells in vivo and in vitro. Eur. J. Immunol. 1986. 16: 735-740.
29. Dumont, F. J., Dijkmans, R., Palfree, R. G., Boltz, R. D. and Coker, L., Selective up-regulation by interferon-gamma of surface molecules of the Ly-6 complex in resting T cells: the Ly-6A/E and TAP antigens are preferentially enhanced. Eur. J. Immunol. 1987. 17: 1183-1191.
30. Snapper, C. M., Yamaguchi, H., Urban, J. F., Jr. and Finkelman, F. D., Induction of Ly-6A/E expression by murine lymphocytes after in vivo immunization is strictly dependent upon the action of IFN-alpha/beta and/or IFN-gamma. Int. Immunol. 1991. 3: 845-852.
31. Taniguchi, T. and Takaoka, A., A weak signal for strong responses: interferon-alpha/beta revisited. Nat. Rev. Mol. Cell Biol. 2001. 2: 378-386.
32. Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002. 20: 709-760.
33. Guiducci, C., Ott, G., Chan, J. H., Damon, E., Calacsan, C., Matray, T., Lee, K. D. et al., Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 2006. 203: 1999-2008.
34. Cisse, B., Caton, M. L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D. et al., Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008. 135: 37-48.
35. Kohara, H., Omatsu, Y., Sugiyama, T., Noda, M., Fujii, N. and Nagasawa, T., Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling. Blood 2007. 110: 4153-4160.
36. Charles, J., Di Domizio, J., Salameire, D., Bendriss-Vermare, N., Aspord, C., Muhammad, R., Lefebvre, C. et al., Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor. J. Invest. Dermatol. 2010. 130: 1646-1656.
37. Sisirak, V., Vey, N., Vanbervliet, B., Duhen, T., Puisieux, I., Homey, B., Bowman, E. P. et al., CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood 2011. 118: 5130-5140.
38. Iparraguirre, A., Tobias, J. W., Hensley, S. E., Masek, K. S., Cavanagh, L. L., Rendl, M., Hunter, C. A. et al., Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide. J. Leukoc. Biol. 2008. 83: 610-620.
39. Kamogawa-Schifter, Y., Ohkawa, J., Namiki, S., Arai, N., Arai, K. and Liu, Y., Ly49Q defines 2 pDC subsets in mice. Blood 2005. 105: 2787-2792.
40. Omatsu, Y., Iyoda, T., Kimura, Y., Maki, A., Ishimori, M., Toyama-Sorimachi, N. and Inaba, K., Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q. J. Immunol. 2005. 174: 6657-6662.
41. Hadeiba, H., Sato, T., Habtezion, A., Oderup, C., Pan, J. and Butcher, E. C., CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008. 9: 1253-1260.
42. Kumar, K. R., Zhu, J., Bhaskarabhatla, M., Yan, M. and Mohan, C., Enhanced expression of stem cell antigen-1 (Ly-6A/E) in lymphocytes from lupus prone mice correlates with disease severity. J. Autoimmun. 2005. 25: 215-222.
43. Bengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H. and Ronnblom, L., Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000. 9: 664-671.
44. Bamezai, A., Palliser, D., Berezovskaya, A., McGrew, J., Higgins, K., Lacy, E. and Rock, K. L., Regulated expression of Ly-6A.2 is important for T cell development. J. Immunol. 1995. 154: 4233-4239.
45. English, A., Kosoy, R., Pawlinski, R. and Bamezai, A., A monoclonal antibody against the 66-kDa protein expressed in mouse spleen and thymus inhibits Ly-6A.2-dependent cell-cell adhesion. J. Immunol. 2000. 165: 3763-3771.
46. Soumelis, V. and Liu, Y. J., From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur. J. Immunol. 2006. 36: 2286-2292.
47. Lombardi, V., Speak, A. O., Kerzerho, J., Szely, N. and Akbari, O., CD8alpha(+)beta(-) and CD8alpha(+)beta(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol. 2012. 5: 432-443.
48. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. et al., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 2003. 4: 1009-1015.
49. Cho, H. J., Hayashi, T., Datta, S. K., Takabayashi, K., Van Uden, J. H., Horner, A., Corr, M. et al., IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 2002. 168: 4907-4913.
50. Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T., DiDonato, J. et al., A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 2003. 170: 4102-4110.
51. Treilleux, I., Blay, J. Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J. P., Bremond, A. et al., Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 2004. 10: 7466-7474.
52. Sisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Renaudineau, S. et al., Impaired IFN-a production by plasmacytoid dendritic cells favors regulatory T cell expansion and contributes to breast cancer progression. Cancer Res. 2012. 72: 5188-5197.
53. Bar-On, L., Birnberg, T., Lewis, K. L., Edelson, B. T., Bruder, D., Hildner, K., Buer, J. et al., CX3CR1+ CD8alpha +dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 2010. 107: 14745-14750.
54. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000. 25: 25-29.